Canagliflozin
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | ||
- | Canagliflozin, sold under the brand name Invokana among others, is a medication used to treat type 2 diabetes. | + | Canagliflozin, sold under the brand name Invokana among others, is a medication used to treat type 2 diabetes. It is used together with exercise and diet. It is not recommended in type 1 diabetes.<ref name="a2">[https://www.drugs.com/monograph/canagliflozin.html "Canagliflozin Monograph for Professionals".] Drugs.com. American Society of Health-System Pharmacists. Retrieved 6 April 2019.</ref> See also [https://en.wikipedia.org/wiki/Canagliflozin Canagliflozin]. |
+ | [[8hdh]]. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 08:04, 24 January 2024
|
References
- ↑ "Canagliflozin Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 6 April 2019.